MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Improve your secondary battery manufacturing

SMC provides a large portfolio of products specially designed for secondary battery industry.

Enhance your expertise with your measuring software

Discover the training options in our ZEISS Metrology Portal.

“Everyone is screaming for talent”

Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Hor...

Positiva data för vaccin i pulverform – ”Fungerar lika bra”

En ny studie indikerar att ett nytt influensavaccin, som utvecklas av Abera Bioscience i samarbete med Orexo, fungerar både som sprej och pulver.

Study: Chat GPT is more empathetic than doctors

The AI tool Chat GPT is not only more accurate when it comes to answering patient questions – the chatbot is also perceived as almost 10 times more empathetic t...

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7 combines high speed digitization and outstanding image quality.

Anna Törner: To kill your darlings

Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...

Mastering Urine Microscopy

On-demand Webinar: Microscopy in urinalysis.

Björn Eriksson ny GD för Socialstyrelsen

I dag, torsdag, meddelade regeringen att det blir Läkemedelsverkets myndighetschef Björn Eriksson som tar över tjänsten som generaldirektör för Socialstyrelsen.

Uncertainty about the government’s life science work

The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now question...

The first drugs to slow down Alzheimer’s – but what does it mean for patients?

New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...

Ny styrelseordförande för Lif

Astra Zenecas Nordenchef, Emelie Antoni, har valts in som ny styrelseordförande för Lif – de forskande läkemedelsföretagen.

Ready-to-install solutions for the lab-on-a-chip

Design for manufacturing lab-on-a-chip devices Reducing time-to-market together

Tungt namn till Alzecure: ”Fantastiskt spännande"

Han har varit global forskningschef för jättebolagen Astra Zeneca och Eli Lilly – nu kliver profilen Jan Lundberg in i Alzecure Pharma.

Conference recordings now available

Don't miss out on insights from leading experts.

Positiva resultat i ny cancerstudie med Imfinzi

Läkemedelsbolaget Astra Zenecas läkemedel Imfinzi (durvalumab), förbättrade signifikant den totala överlevnaden och progressionsfri överlevnad för patienter med...

Amrop Malmö AB

Save time and money !

Festo Digital engineering tools helps you to calculate the most cost and efficient solution for your application for free

Uppgifter: Astra Zeneca planerar avknoppning i Kina

Astra Zeneca har planer på att knoppa av sin verksamhet i Kina och låta notera den separat i Hongkong. Det rapporterar Financial Times som uppger att åtgärden s...

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Marie Gårdmark: “What to expect from Trump’s second term?”

One may complain about the complex multinational system in EU, but it gives us some predictability that cannot be easily overturned by different member states p...

Swedish-Danish meeting at Medicon Village: “One of the most important life science congresses”

For the eleventh year, The Future of Swedish and Danish Life Science was held on Wednesday, and the event continues to function as a connecting link between the...

BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”

For the first time since its inception, AstraZeneca’s BioVentureHub can now recruit new companies, as some of its tenants have grown significantly and are leavi...